Glial neoplasms: Dynamic contrast-enhanced T2*-weighted MR imaging

Radiology

Volumn 211, Issue 3, 1999, Pages 791-798

  Knopp, Edmond A ^a   Cha, Soonmee ^a   Johnson, Glyn ^a   Mazumdar, Avi ^a   Golfinos, John G ^a   Zagzag, David ^a   Miller, Douglas C ^a   Kelly, Patrick J ^a   Kricheff, Irvin I ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Astrocytoma; Brain neoplasms; Brain neoplasms, diagnosis; Brain, perfusion; Magnetic resonance (MR), perfusion study; Stereotaxis

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEREOTAXIC SURGERY; TUMOR DIAGNOSIS;

EID: 0033004433     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.211.3.r99jn46791     Document Type: Article

References (32)

1. Burger PC, Vogel FS. The brain: tumors. In: Burger PC, Vogel FS, eds. Surgical pathology of the central nervous system and its coverings. New York, NY: Wiley, 1982; 223-266.
2. Burger PC, Vogel FS, Green SB, et al. Glioblastoma multiforme and anaplastic astrocytoma: pathologic criteria and prognostic implications. Cancer 1985; 56: 1106-1111.
3. Daumas-Duport C, Scheithauer B, O'Fallon J, et al. Grading of astrocytomas: a simple and reproducible method. Cancer 1988; 62:2152-2165.
4. Ringertz J. Grading of gliomas. Acta Pathol Microbiol Scand 1950; 27:51-64.
5. Kelly PJ, Daumas-Duport C, Scheithauer BE, et al. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987; 62:450-459.
6. Burger P. Malignant astrocytic neoplasms: classification, pathology, anatomy, and response to therapy. Semin Oncol 1986; 13:16-20.
7. Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression in angiogenic vessels of human astrocytomas and by human endothelial cells in vitro. Cancer Res 1996; 56:182-189.
8. Brem S. The role of vascular proliferation in the growth of brain tumors. Clin Neurosurg 1976; 23:440-453.
9. Ausprunk D, Folkman J. Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 1977; 14:52-65.
10. Felix R, Schorner W, Laniado M, et al. Brain tumors: MR imaging with gadolinium-DTPA. Radiology 1985; 156:681-688.
11. Brasch RC, Weinmann HJ, Wesbey GE. Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. AJR 1984; 142:625-630.
12. Grossman I, Wolf G, Biery D, et al. Gadolinium-enhanced nuclear magnetic resonance images of experimental brain abscess. J Comput Assist Tomogr 1984; 8:204-207.
13. Zhang W, Williams DS, Koretsky AP. Measurement of rat brain perfusion by NMR using spin labeling of arterial water: in vivo determination of the degree of spin labeling. Magn Reson Med 1993; 29:416-421.
14. Edelman RR, Siewert B, Darby DG, et al. Qualitative mapping of cerebral blood flow and functional localization with echo-planar MR imaging and signal targeting with alternating radio frequency. Radiology 1994; 192:513-520.
15. Kim SG. Quantification of relative cerebral blood flow change by flow-sensitive alternating inversion recovery (FAIR) technique: application to functional mapping. Magn Reson Med 1995; 34:293-301.
16. Detre JA, Leigh JS, Williams DS, et al. Perfusion imaging. Magn Reson Med 1992; 23:37-45.
17. Alsop DC, Detre JA. Multisection cerebral blood flow MR imaging with continuous arterial spin labeling. Radiology 1998; 208: 410-416.
18. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
19. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 1990; 176:211-220.
20. Rosen BR, Belliveau JW, Vevea JM, et al. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
21. Edelman RR, Wielopolski P, Schmitt F. Echo-planar MR imaging. Radiology 1994; 192:600-612.
22. Weisskoff R, Belliveau J, Kwong K, et al. Functional MR imaging of capillary hemodynamics. In: Potchen E, ed. Magnetic resonance angiography: concepts and applications. St Louis, Mo: Mosby, 1993; 473-484.
23. Press WH, Flannery BP, Teukolsky SA, et al. Numerical recipes in C: the art of scientific computing. Cambridge, Mass: Cambridge University Press, 1988.
24. Johnson G, Hutchison JMS. The limitations of NMR recalled-echo imaging techniques. J Magn Reson 1985; 63:14-30.
25. Brem S, Cotran R, Folkman J. Tumor angiogenesis: a quantitative method for histologic grading. J Natl Cancer Inst 1972; 48:347-356.
26. Scherer HJ. The forms of growth in gliomas and their practical significance. Brain 1940; 63:1-35.
27. Fulling KH, Garcia DM. Anaplastic astrocytoma of the adult cerebrum: prognostic value of histologic features. Cancer 1985; 55:928-931.
28. Maxwell M, Naber SP, Wolfe HJ, et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res 1991; 51:1345-1351.
29. Le Bihan D, Douek M, Argyropoulou M, et al. Diffusion and perfusion magnetic resonance imaging in brain tumors. Top Magn Reson Imaging 1993; 5:25-31.
30. Weisskoff RM, Zuo CS, Boxerman JL, et al. Microscopic susceptibility variation and transverse relaxation: theory and experiment. Magn Reson Med 1994; 31:601-610.
31. Ernest FI, Kelly PJ, Scheithauer BW, et al. Cerebral astrocytomas: histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 1988; 166:823-827.
32. Fan KJ, Kovi J, Earle K. The ethnic distribution of primary central nervous system tumors: AFIP 1958 to 1970. J Neuropathol Exp Neurol 1977; 36:41-49.